Revance Therapeutics, Inc. 4
4 · Revance Therapeutics, Inc. · Filed May 14, 2015
Insider Transaction Report
Form 4
Eastman Ronald W
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2015-05-07+8,000→ 8,000 totalExercise: $20.42Exp: 2025-05-06→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option shall vest on the one year anniversary of May 7, 2015, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) through such vesting date. The stock option represents an annual option grant pursuant to the Issuer's Non-Employee Director Compensation Policy.